hammerhead ribozymes (Thomas Jefferson/Connecticut Universities)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Namehammerhead ribozymes (Thomas Jefferson/Connecticut Universities)

Drug Alias Namealpha1-AT modulator (Thomas Jefferson/Connecticut Universities)alpha1-AT expression modulator (Thomas Jefferson/Connecticut Universities)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > RibozymeSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide

Mechanisms of ActionAlpha-1-antiproteinase modulators

TargetsAlpha-1-antiproteinase

Therapy Area/IndicationsEmphysemaLiver Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThomas Jefferson University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThomas Jefferson University University Of Connecticut

Active IndicationsN/A

Inactive IndicationsEmphysemaLiver Diseases

Other Information

ATC CodeN/A